Skip to main content
Log in

Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia

  • Published:
Archiv für Psychiatrie und Nervenkrankheiten Aims and scope Submit manuscript

Summary

Monoamine oxidase (MAO) activity has been measured in the platelets of controls (n=42) and schizophrenic patients (n=49) of three subtypes, using β-phenylethylamine, p-tyramine, and tryptamine as substrates. Characteristic differences of MAO activity were observed between platelets of patients and controls; the differences were substrate-typic: decreased enzyme activity was found with all three substrates in platelets of the parnaoid subtype. With tryptamine, MAO activity was decreased in the platelets of all three sub-types of schizophrenia. With p-tyramine, MAO was low in patients with affective psychoses and paranoid schizophrenia.

The value of MAO activity measurements as a means for distinguishing sub-types of schizophrenic disorders is improved by using two substrates; tryptamine and p-tyramine. Possible mechanisms of the substrate-typic changes of platelet MAO activity in schizophrenia are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Belmaker, R. H., Murphy, D. L., Wyatt, R. J., Loriaux, D. L.: Human platelet monoamine oxidase changes during estrogen cycle. Arch. Gen. Psychiat. 31, 553–556 (1974)

    Google Scholar 

  • Bhagat, B., Bryan, R. J., Lee, Y.-C.: Increase in adrenal monoamine oxidase activity in hypophysectomized rats after ACTH. Neuropharmacol. 12, 1199–1202 (1973)

    Google Scholar 

  • Brockington, I, Crow, T. J., Johnstone, E. C., Owen, F.: An investigation of platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis. In: Monoamine oxidase and its inhibition, p. 353. Amsterdam: A Ciba Foundation Symposium, Elsevier 1976

    Google Scholar 

  • Carpenter, W. T., Murphy, D. L., Wyatt, R. J.: Platelet monoamine oxidase activity in acute schizophrenia. Am. J. Psychiat. 132, 438–441 (1975)

    Google Scholar 

  • Christ, W., Rakow, D., Honecker, H., Coper, H.: Bestimmung der Monoamin-oxidase und Catechol-0-methyltransferase in menschlichen Blutbestandteilen. Arzneim.-Forsch. 26, 1151–1152 (1976)

    Google Scholar 

  • Collins, G. G. S., Pryse-Davies, J., Sandler, M., Southgate, J.: Effect of pretreatment with oestradiol, progesteron, and Dopa on monoamine oxidase activity in the rat. Nature 226, 642–643 (1970)

    Google Scholar 

  • Collins, G. G. S., Sandler, M.: Human blood platelet monoamine oxidase. Biochem. Pharmacol. 20, 289–296 (1971)

    Google Scholar 

  • Degkwitz, R., Helmchen, H., Kockott, G., Mombour, W.: Diagnoseschlüssel und Glossar psychiatrischer Krankheiten. Deutsche Ausgabe der internationalen Klassifikation der WHO: ICD (International classification of diseases), 8. Rev. Berlin-Heidelberg-New York: Springer 1975

    Google Scholar 

  • Demisch, K., Demisch, L.: Activity of human platelet monoamine oxidase in endocrine diseases and during endocrine function tests. Acta Endocrinol. Suppl. 208, 109 (1977)

    Google Scholar 

  • Demisch, L., Bochnik, H. J., Seiler, N.: A routine assay procedure for monoamine oxidase and its application to human blood platelets. Clin. Chim. Acta 70, 357–369 (1976)

    Google Scholar 

  • Domino, E. F., Khanna, S. S.: Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients. Am. J. Psychiat. 133, 323–326 (1976)

    Google Scholar 

  • Edwards, D. J., Burns, M. O.: Effects of tricyclic antidepressants upon human platelet monoamine oxidase. Life Sci. 15, 2045–2058 (1974)

    Google Scholar 

  • Eleftheriou, B. E., Boehlke, K. W.: Brain monoamine oxidase in mice after exposure to aggression and defeat. Science 155, 1693–1694 (1967)

    Google Scholar 

  • Friedman, E., Shopsin, B., Sathananthan, G., Gershon, S.: Blood platelet monoamine oxidase activity in psychiatric patients. Am. J. Psychiat. 131, 1392–1394 (1974)

    Google Scholar 

  • Gandhi, B. S., Kanungo, M. S.: Effect of cortisone on monoamine oxidase of the liver of young and old rats. Ind. J. Biochem. Biophys. 11, 102–104 (1974)

    Google Scholar 

  • Gentil, V., Greenwood, M. H., Lader, M. H.: The effect of adrenaline on human platelet MAO activity. Psychopharmacol. 44, 187–190 (1975)

    Google Scholar 

  • Goridis, C., Neff, N. H.: Neuronal and hormonal influences on the turnover of monoamine oxidase in salivary gland. Biochem. Pharmacol. 22, 2501–2510 (1973)

    Google Scholar 

  • Gorkin, V. Z.: Transformation of monoamine oxidases and deamination of fatty-aromatic monoamines. In: Frontiers in catecholamine research (E. Usdin, S. H. Snyder, eds.), pp. 151–152. New York: Pergamon Press 1973

    Google Scholar 

  • Gorkin, V. Z.: Monoamine oxidase inhibitors and the transformation of monoamine oxidases. In: Monoamine oxidase and its inhibition. Ciba Foundation Symp. 39, pp. 61–79. Amsterdam: Elsevier, Excerpta Medica 1976

    Google Scholar 

  • Gorkin, V. Z., Akopyan, Zh. I, Veryovkina, I. V., Stesina, L. N., Abdel Samed, M. M.: Effects of monoamine oxidase inhibitors on qualitative alterations (“transformation”) of the catalytic properties of amine oxidases. Biochem. J. 121, 31P (1971)

  • Gorkin, V. Z., Tatyanenko, L. T.: “Transformation” of mitochondrial monoamine oxidase into a diamine oxidase-like enzyme in vitro. Biochem. Biophys. Res. Commun. 27, 613–617 (1967)

    Google Scholar 

  • Grosso, D. S., Gawienowski, A. M.: Modification of rat uterine monoamine oxidase activity by steroid hormones. J. Endocrinol. 65, 207–214 (1975)

    Google Scholar 

  • Hawk, B. B., Carpenter, W. T., Strauss, J. S.: Diagnostic criteria and five year outcome in schizophrenia. A report from the international pilot study of schizophrenia. Arch. Gen. Psychiat. 32, 343–347 (1975)

    Google Scholar 

  • Honecker, H., Hill, R.: Does long term treatment with amitryptiline alter the monoamine oxidase of rat brain? Pharmacopsychiat. Neuro-Psychopharmacol. 10, 32–35 (1977)

    Google Scholar 

  • Houslay, M. D., Tipton, K. F.: Multiple forms of monoamine oxidase. Fact and artifact. Life Sci. 19, 467–478 (1976)

    Google Scholar 

  • Maura, G., Vaccari, A.: Relationships between age of submission to environmental stress and monoamine oxidase activity in rats. Experientia 31, 191–193 (1975)

    Google Scholar 

  • Maura, G., Vaccari, A., Gemignani, A., Cugurra, F.: Development of monoamine oxidase activity after chronic and environmental stress in the rat. Environ. Physiol. Biochem. 4, 64–79 (1974)

    Google Scholar 

  • Meltzer, H. Y., Stahl, S. M.: Platelet monoamine oxidase activity in schizophrenic patients. Res. Commun. Chem. Pharmacol. 7, 419–431 (1974)

    Google Scholar 

  • Murphy, D. L.: Technical strategies for the study of catecholamines in man. In: Frontiers in catecholamine research (E. Usdin, S.H. Snyder, eds.), pp. 1077–1082. New York: Pergamon Press 1973

    Google Scholar 

  • Murphy, D. L., Belmaker, R., Carpenter, W. T., Wyatt, R. J.: Monoamine oxidase in chronic schizophrenia: studies of hormonal and other factors affecting enzyme activity. Brit. J. Psychiat. 130, 151–158 (1977)

    Google Scholar 

  • Murphy, D.L., Donelly, C.H.: Monoamine oxidase in man: Enzyme characteristics in platelets, plasma, and other human tissues. In: Neuropsychopharmacology of monoamines and their regulatory enzymes (E. Usdin, ed.), pp. 71–85. New York: Raven Press 1974

    Google Scholar 

  • Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L., Wyatt, R. J.: Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability overtime. Biochem. Med. 16, 254–265 (1976)

    Google Scholar 

  • Murphy, D. L., Wyatt, R. J.: Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature 238, 225–226 (1972)

    Google Scholar 

  • Murphy, D. L., Wyatt, R. J.: Monoamine oxidase in schizophrenia and other behavioral disorders. J. Psychiat. Res. 11, 221–247 (1974)

    Google Scholar 

  • Murphy, D. L., Wyatt, R. J.: Neurotransmitter related enzymes in the major psychiatric disorders: I. Catechol-0-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities. In: Biology of the major psychoses: A comparative analysis (D. X. Freedman, ed.), pp. 277–288. New York: Raven Press 1975

    Google Scholar 

  • Nies, A., Robinson, D. S., Lamborn, K. L., Lampert, R. P.: Genetic control of platelet and plasma monoamine oxidase activity. Arch. Gen. Psychiat. 28, 834–838 (1973)

    Google Scholar 

  • Nies, A., Robinson, L. S., Lamborn, K. R.: Comparison of monoamine oxidase, substrate activities in schizophrenic twins, depressives and controls. In: Neuropsychopharmacology of monoamines and their regulatory enzymes (E. Usdin, ed.), pp. 59–70. New York: Raven Press 1974

    Google Scholar 

  • Owen, F., Ridges, A. P., Cookson, I. B.: Monoamine oxidase activity: A genetic marker of schizophrenia? Acta Genet. Med. Gemellol. (Roma) 23, 371–376 (1974)

    Google Scholar 

  • Parvez, H., Parvez, S.: The regulation of monoamine oxidase activity by adrenal cortical steroids. Acta Endocrinol. 73, 509–517 (1973)

    Google Scholar 

  • Petrovic, V. M., Janić, V.: Adrenocortical control of monoamine oxidase activity in the ground squirrel (Citellus citellus) during the winter. J. Endocrinol. 62, 407–408 (1974)

    Google Scholar 

  • Philipson, O. T., Sandler, M.: The effect of hydrocortisone and adrenocorticotrophic hormones on monoamine oxidase and tyrosine hydroxylase in explant cultures of embryonic sympathetic ganglia. Brain Res. 90, 283–296 (1975)

    Google Scholar 

  • Redmond, D. E., Murphy, D. L., Baulu, J., Ziegler, M. G., Lake, C. R.: Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine-beta-hydroxylase (DBH) activities in the Rhesus monkey. Psychosom. Med. 37, 417–428 (1975)

    Google Scholar 

  • Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. C., Sylvester, D.: Relation of sex and aging to monoamine oxidase activity of human brain, plasma and platelets. Arch. Gen. Psychiat. 24, 536–539 (1971)

    Google Scholar 

  • Schildkraut, J. J., Herzog, J. M., Orsulak, P. J., Edelman, S. E., Shein, H. M., Frazier, S. H.: Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am. J. Psychiat. 133, 438–440 (1976)

    Google Scholar 

  • Shaskan, E. G., Becker, R. E.: Platelet monoamine oxidase in schizophrenics. Nature 253, 659 (1975)

    Google Scholar 

  • Strauss, J. S., Carpenter, W. T.: The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: A report from the WHO international pilot study of schizophrenia. Arch. Gen. Psychiat. 31, 37–42 (1974)

    Google Scholar 

  • Strauss, J. S., Carpenter, W. T.: The key clinical dimensions of the functional psychoses. In: Biology of the major psychoses: A comparative analysis (D. X. Freedman, ed.), pp. 9–17. New York: Raven Press 1975

    Google Scholar 

  • Tipton, K. F., Houslay, M. D., Mantle, T. J.: The nature and locations of the multiple forms of monoamine oxidase. In: Monoamine oxidase and its inhibitors, p. 5. Amsterdam: Ciba Foundation Symposium, Elsevier 1976

    Google Scholar 

  • Tsuang, M. T., Winokur, P.: Criteria for subtyping schizophrenia. Clinical differentiation of hebephrenic and paranoid chizophrenia. Arch. Gen. Psychiat. 33, 43–47 (1974)

    Google Scholar 

  • Wurtmann, R. J., Axelrod, J.: Sex steroids, cardiac 3H-norepinephrine, and tissue monoamine oxidase levels in the rat. Biochem. Pharmacol. 12, 1417–1419 (1963)

    Google Scholar 

  • Wyatt, R. J., Belmaker, R., Murphy, D. L.: Low platelet monoamine oxidase and vulnerability to schizophrenia. Mod. Probl. Pharmacopsychiatry 10, 57–64 (1975)

    Google Scholar 

  • Wyatt, R. J., Murphy, D. L.: Neurotransmitter related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia. In: Biology of the major psychoses: A comparative analysis (D. X. Freedman, ed.), pp. 289–297. New York: Raven Press 1975

    Google Scholar 

  • Wyatt, R. J., Murphy, D. L., Belmaker, R., Donelly, C. H., Pollin, W.: Reduced monoamine oxidase activity in platelets: A genetic marker for vulnerability to schizophrenia. Science 179, 916–918 (1973)

    Google Scholar 

  • Youdim, M. B. H., Holzbauer, M., Woods, H. F.: Physicochemical properties, development and regulation of central and peripheral monoamine oxidase activity. In: Neuropsychopharmacology of monoamines and their regulatory enzymes (E. Usdin, ed.), pp. 11–28. New York: Raven Press 1974

    Google Scholar 

  • Youdim, M. B. H., Woods, H. F.: The influence of tissue environment on the rates of metabolic processes and the properties of enzymes. Biochem. Pharmacol. 24, 317–323 (1975)

    Google Scholar 

  • Zeller, E. A., Boshes, B., Arbit, J., Bieber, M., Blonsky, E. R., Dolkart, M., Huprikar, S. V.: Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-Dopa on platelet monoamine oxidase. J. Neural Transmission 39, 63–77 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demisch, L., von der Mühlen, H., Bochnik, H.J. et al. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia. Arch. Psychiat. Nervenkr. 224, 319–329 (1977). https://doi.org/10.1007/BF00341614

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00341614

Key words

Navigation